home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Evidence Supports 'One-Hit' Model of Cell Death in Neurogenerative Disease

  July, 14 2000 7:02
your information resource in human molecular genetics

Neuronal death is behind Alzheimer's disease, Parkinson's disease and the sudden loss of motor function in patients suffering from amyotrophic lateral sclerosis (also known as Lou Gehrig's disease). Attempts to understand these and other neurodegenerative disorders have been complicated by their varying times of onset and clinical courses. Might the loss of neurons in all of these diseases follow a common principle? Or does the neuronal death in each have its own rules and regulations?

This week (Nature, Vol. 406, Issue 6792, July 13, 2000) Roderick R. McInnes of The Hospital for Sick Children and the University of Toronto, Ontario, and colleagues provide experimental evidence to support a common, 'one-hit' model of cell death in neurodegenerative diseases that has implications for treatment strategies. Their findings argue against the cumulative-damage hypothesis, indicating instead that the time of death of any neuron is random.

"These results are certain to stimulate much debate and experimentation, aimed both at identifying common mechanisms of neurodegeneration and at developing common ways of intervening in these tragic diseases", says Nathaniel Heintz of the Howard Hughes Medical Institute, Rockefeller University, New York, in an accompanying News and Views article.


Roderick R McInnes tel +1 416 813 6383, fax +1 416 813 4931,
e-mail mcinnes@sickkids.on.ca

Nathaniel Heintz tel +1 212 327 7956, fax +1 212 327 7878,
e-mail heintz@rockvax.rockefeller.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.